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A B S T R A C T
Human trichomoniasis, caused by the protozoan Trichomonas vaginalis, is a highly prevalent sexually
transmitted infection. However, little is known about the degree of strain variability of T. vaginalis.
A reliable classification method for T. vaginalis strains would be a useful tool in the study of the
epidemiology, pathogenesis and transmission of T. vaginalis. A PCR–restriction fragment length
polymorphism typing method was designed and evaluated using T. vaginalis isolates obtained after
culture of vaginal specimens collected in the Democratic Republic of Congo and in Zambia. The
variation of the actin gene of T. vaginalis was determined for three ATCC reference strains and 151
T. vaginalis isolates. Eight different types were identified, on the basis of the digestion patterns of the
amplified actin gene, with each of the restriction enzymes HindII, MseI and RsaI. It was determined that
the ATCC reference strains 30001, 30240 and 50141 were of actin genotypes G, H and E, respectively.
The actin genotype type E was more common in the Democratic Republic of Congo, whereas type G
was the commonest type in Zambia. Translation of the nucleotide sequence showed up to three amino
acid substitutions. We developed a reproducible, sensitive and specific typing method for T. vaginalis,
and were able to distinguish at least eight T. vaginalis actin genotypes. Further studies are needed to
evaluate the method using clinical specimens and to determine the utility of the typing method for the
genotypic characterization of T. vaginalis.
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I N T R O D U C T I O N
Trichomoniasis is the most common curable
sexually transmitted infection (STI) globally [1].
Trichomonas vaginalis causes vaginitis, urethritis,
and cervicitis, but infection with T. vaginalis is
frequently asymptomatic in both men and women
[2]. Trichomoniasis increases the risk of pelvic
inflammatory disease, infertility and adverse
pregnancy outcome [3–5]. Trichomoniasis has
also been found to be associated with an
increased risk of human immunodeficiency virus
transmission and acquisition [6–9].
There are still many unresolved questions
regarding the epidemiology, pathogenicity and
transmission of T. vaginalis, as well as drug
resistance. Research in order to answer some of
these questions would be greatly aided by a
reliable classification method for T. vaginalis.
Studies of proteins, polysaccharides and isoen-
zyme profiles of T. vaginalis have shown that
strain differences do exist, but attempts to
develop a classification system based on biolog-
ical differences, such as virulence, have so far
been unsuccessful [10,11]. The development of
DNA-based techniques offers new perspectives,
and there are already several examples in the
literature of the application of molecular methods
to the study of the genetic diversity of parasites
[12]. These methods include PCR–hybridization,
PCR–size polymorphism, PCR–restriction frag-
ment length polymorphism (PCR-RFLP) and
random amplification of polymorphic DNA
(RAPD) [12]. PCR fingerprinting by RAPD anal-
ysis and RFLP analysis are techniques that have
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been used to study variation in T. vaginalis
[13–16]. These techniques, however, have their
limitations. The reproducibility and reliability of
RAPD have been found to be poor, and RFLP has
low analytical sensitivity, due to the lack of an
amplification step [15].
The ideal method for classifying T. vaginalis
strains should have the sensitivity of PCR and the
reliability of RFLP [12]. The PCR-RFLP technique
combines PCR and RFLP and can reveal minor
variations in a gene where a single base substitu-
tion has created or abolished a recognition site for
the restriction endonuclease enzyme. The tech-
nique has proven its usefulness for the strain
typing of different organisms, including Chlamydia
trachomatis, Treponema pallidum and Neisseria
gonorrhoeae [17–19]. The present article describes
the application of this technique in an attempt to
develop a reproducible, sensitive and specific
molecular typing method for T. vaginalis.
M A T E R I A L S A N D M E T H O D S
Isolates
Reference trichomonad strains. Fourteen strains that were repre-
sentative of the family Trichomonadidae were used to assess
specificity (Table 1). T. vaginalis ATCC 30001 was used in
titration experiments to determine the analytical sensitivity of
the PCR-RFLP assay.
The trichomonad trophozoites were cultured in modified
trypticase yeast maltose medium [20] and incubated at 37C
under aerobic conditions. The pH of the medium was adjusted
according to the requirement of the respective trichomonad.
Vaginal specimens. Vaginal specimens for T. vaginalis culture
were obtained from female sex workers (FSWs) in Kinshasa
(Democratic Republic of Congo) and Zambia. In Kinshasa,
specimens were collected as part of a study on the prevalence
of human immunodeficiency virus and other STIs among
women attending a dedicated clinic for sex workers. The
methods of this study have been described in detail else-
where [21]. Samples of vaginal secretions were collected by a
health worker during pelvic examination, using a sterile
cotton swab. In Zambia, specimens were collected as part of
the 2003 behavioural and biological surveillance survey
(BBSS) among FSWs, which was carried out by Family
Health International (Family Health International. Behavio-
ural and biologic surveillance survey in selected transporta-
tion border routes, Zambia. Assessment between 2000 and
2003. Surveillance Studies Among Female Sex Work-
ers. http://www.fhi.org/en/HIVAIDS/pub/index.htm). Par-
ticipants were recruited at night at their place of work.
Consenting FSWs were interviewed and requested to submit
samples for testing for STIs. Self-administered vaginal swabs
were collected for the diagnosis of gonorrhoea, chlamydial
infection and trichomoniasis. Swabs collected in Kinshasa and
in Zambia were processed in the same way. They were
immediately inoculated in InPouch culture medium, follow-
ing the manufacturer’s instructions (Biomed Diagnostics, San
Jose, CA, USA). The culture media were incubated at 37C for
a maximum of 5 days. After final microscopic reading, the
pouches were stored at –20C until shipment on dry ice to the
Institute of Tropical Medicine in Antwerp, Belgium. Upon
arrival, the culture media were stored at –20C until tested.
Prior to analysis, all participant identifiers were removed
from the InPouch samples. An InPouch sample was consid-
ered to be positive for T. vaginalis if microscopy performed at
the study site had been positive or if the sample tested
positive on two independent PCR assays using the TVK3 ⁄ 7
and IP1 ⁄ IP2 primer sets [22,23]. A more detailed description
of these PCR assays is given elsewhere [24].
DNA extraction
The genomic DNA from the trichomonads obtained by culture
in trypticase yeast maltose or InPouch medium was extracted
with the QIAamp DNA minikit (Qiagen, Hilden, Germany),
following the manufacturer’s instructions. An aliquot of
500 lL of culture medium was extracted, and DNA was
eluted with 250 lL of Tris–acetate–EDTA buffer (pH 7.4).
PCR-RFLP
The target of the nested PCR was chosen within the actin gene.
The outer primers (OPs) and inner primers (IPs) were chosen
within an actin gene sequence belonging to a specific family of
at least nine members of actin genes from the T. vaginalis
genome (GenBank accession number AF237734) [25]. The OPs
used were Tv8S (5¢-TCTGGAATGGCTGAAGAAGACG-3¢)
and Tv9R (5¢-CAGGGTACATCGTATTGGTC-3¢), and the IPs
used were Tv10S (5¢-CAGACACTCGTTATCG-3¢) and Tv11R
(5¢-CGGTGAACGATGGATG-3¢). The primers were synthe-
sized by Eurogentec (Seraing, Belgium). The size of the target
was 1100 bp, which is only 28 bp shorter than the full length of
the open reading frame of the actin gene.
The PCR mixture consisted of Expand High Fidelity
buffer, 3 mmol ⁄L MgCl2, 280 lmol ⁄L deoxyribonucleoside
triphosphates (Pharmacia Biotech, St Albans, UK), 0.3 lmol ⁄L
of each primer of the primer sets (Tv8S, Tv9R) and (Tv10S,
Tv11R), and 1.7 U of Expand High Fidelity DNA polymerase.
The Expand High Fidelity was purchased in a kit format,
which included Expand High Fidelity 10· buffer, MgCl2
solution, and Expand High Fidelity Enzyme mix containing
Table 1. Strains included in the analytical specificity tests
Species Strain and source
Trichomonas vaginalis ATCC 30001, ATCC 30240,
ATCC 50141, ATCC 50144
Trichomonas gallinae ATCC 30002
Tritrichomonas suis ATCC 30169
Trichomonas tenax ATCC 30207
Pentatrichomonas hominis ATCC 30000, ATCC 30098
Pentatrichomonas hominis PHKT, received from J. Kulda
Trichomonas vaginalis Tv 17-48, received from J. Kulda
Tritrichomonas foetus KVCL, received from J. Kulda
Trichomonas gallinae TGK, received from J. Kulda
Tetratrichomonas gallinarum gallinarum 1-11 M2, received from J. Kulda
The strains with origin ATCC were obtained from the American Type Culture
Collection.
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Taq DNA polymerase and Tgo DNA polymerase (Roche
Applied Science, Penzberg, Germany). The volume was
adjusted to 40 lL with Milli-Q water, and 10 lL of culture
DNA extract was added to each reaction mixture for the
amplification with the OPs. The same reaction mixture was
prepared for amplification with the IPs, the volume was
adjusted to 49 lL with Milli-Q water, and 1 lL of amplified
product was added to each reaction mixture.
PCR amplification was performed in two stages in a
thermocycler (Perkin-Elmer, Cetus, Norwalk, CT, USA). The
first stage consisted of a total of ten cycles. Each cycle consisted
of 30 s of denaturation at 94C, 30 s of annealing at 55C, and a
3 min extension at 72C. The first cycle was preceded by 5 min
of denaturation at 95C. The second stage consisted of 25
cycles with the same denaturation and annealing steps. The
extension step was extended by 5 s per cycle.
The last cycle was followed by a 7 min final extension at
72C. Upon completion of PCR, 15 lL of each amplified
specimen was analyzed by electrophoresis in a 2% agarose
gel in Tris–acetate–EDTA buffer (pH 8.5). The gel was
stained with ethidium bromide (0.5 mg ⁄L; Sigma, Bornem,
Belgium) and was photographed under short-UV light. The
size of the amplified products was assessed by comparing
them with a commercial weight marker, Smartladder (Euro-
gentec).
After visualization of the amplified product, 5 lL was
digested for 4 h at 37C with restriction endonucleases HindII,
MseI and RsaI, respectively. The restriction endonucleases
HindII and RsaI were purchased from Roche Molecular Bio-
chemicals (Mannheim, Germany) andMseI from New England
BioLabs Inc. (Ipswich,MA,USA). The fragmentswere separated
using 3% agarose gel in Tris–acetate–EDTAbuffer (pH 8.5). The
gel was stained with ethidium bromide (0.5 mg ⁄L; Sigma) and
was photographed under short-UV light. The size of the
amplified products was assessed using a 100-bp commercial
weight marker, Smartladder SF (Eurogentec).
All assays were performed according to standard quality
assurance guidelines for molecular diagnosis [26,27]. In addi-
tion, each test run included one negative and one positive
control. The negative control consisted of the reaction mixture
with water instead of DNA extract, and the positive control
was a previously typed T. vaginalis ATCC reference strain,
randomly selected from among the ATCC reference strains at
each run. Testing was considered valid if, after nested PCR, no
amplified product was detected in the negative control and if,
after digestion, the reference ATCC strain gave the previously
determined actin genotype.
Sequencing
Amplicons from the T. vaginalis reference strains ATCC 30001,
ATCC 30240 and ATCC 50141 and six clinical isolates (four
from Zambia and two from Kinshasa) were sequenced to
determine the size of the fragments and to confirm the banding
patterns. Sequencing was performed by VIB Genetic Service
Facility (Wilrijk, Belgium) using capillary sequencers (Applied
Biosystems 3730 DNA Analyzer) combined with ABI PRISM
BigDye Terminator cycle sequencing kits. In addition, the use
of the ABI Genetic Analyzer for the determination of fragment
size and banding patterns ensured that the results were
unbiased.
The nucleotide sequences were deposited at GenBank
under accession numbers EU076578–EU076586.
Assessment of analytical sensitivity
In order to determine the analytical sensitivity of the nested
PCR technique, a ten-fold serial dilution of T. vaginalis troph-
ozoites in Tris–acetate–EDTA buffer (pH 8.5) was extracted, as
described above, and tested. The T. vaginalis trophozoites were
counted in a Neubauer counting chamber.
Assessment of clinical sensitivity
An InPouch sample was considered to be truly positive for
T. vaginalis if motile trichomonad trophozoites had been
observed using microscopy or if the sample tested positive
using PCR with two different primer sets (TVK3 ⁄ 7 and
IP1 ⁄ IP2). The sensitivity of the nested PCR assay performed
on the InPouch media was calculated using this definition of
positivity as an expanded reference standard. Estimates of
the sensitivity with 95% CIs were made using standard
methods.
Assessment of robustness and reproducibility
A panel of 14 DNA extracts of T. vaginalis isolates was
amplified by nested PCR and digested twice by the restriction
enzymes at two different points in time with an interval of 4 h.
The same panel of DNA extracts was amplified by nested
PCR, 2 days after the first amplification run, and again
digested by the restriction enzymes at two separate time
points with an interval of 4 h.
R E S U L T S
Species specificity of the nested PCR
The actin gene nested PCR assay amplified all
T. vaginalis reference strains but not trichomonad
species other than T. vaginalis. There was also no
amplification of sterile InPouch medium.
Sensitivity of the nested PCR
The analytical sensitivity of the nested PCR assay
was determined to be equivalent to ten trichomo-
nad trophozoites per reaction.
In total, 160 InPouch extracts that were positive
according to the expanded reference standard
were analyzed using the actin gene nested PCR
assay. Five of these InPouch media were initially
considered to be negative for T. vaginalis at the
study site but were found to be positive on the
two independent PCR assays. The actin gene
nested PCR amplified 151 ⁄ 160 of the isolates,
giving a clinical sensitivity of the nested PCR of
94.4% (95% CI 91.0–99.3). Of the nine isolates
from which no amplified product was obtained
with the actin gene nested PCR assay, five were
also negative on the two primer set PCRs.
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RFLP patterns
Digestion of the amplified product with HindII
yielded three distinct DNA fragments of 827, 213
and 60 bp or four DNA fragments of 426, 401, 213
and 60 bp.
All isolates showed the 60 bp and 213 bp single
bands. The presence of the 426 bp and 401 bp or
827 bp single fragments allowed classification of
the isolates into one of two groups.
The restriction enzyme MseI digested the ampli-
fied products into two or three fragments. Three
groups could be distinguished on the basis of the
presence of one fragment band of 519 bp or two
fragmentbandsof333 and186 bpor315and204 bp,
besides the 581 bp fragment present in all isolates.
Four different DNA fragment patterns were
obtained after digestion of the amplified products
with the restriction enzyme RsaI. Each pattern
consisted of a minimum of four fragments. All of
them showed bands of 236 and 106 bp. Differ-
ences among the patterns were based on the
presence or absence of the 568 bp vs. 452 bp and
116 bp fragments, and of the 190 bp vs. 103 bp
and 87 bp fragments.
By combining the DNA fragment patterns, eight
distinct types could be identified. An isolate was
considered to be a mixture of T. vaginalis strains if
the total sum of the different fragments obtained
with one specific restriction enzyme was superior
to the target size of 1100 bp. However, simulta-
neous amplification of anothermember of the actin
gene familywith adifferent pattern cannot be ruled
out. The exact size of the DNA fragments was
determined by sequencing the amplicons of the
T. vaginalis reference strains and by sequencing six
clinical isolates as described above underMethods.
In conclusion, digestion of the amplified prod-
ucts with HindII,MseI and RsaI yielded two, three
and four different digestion patterns, respectively.
Genotypes were designated according to the
combination of digestion patterns. Genotype A
was defined as showing pattern 1 after HindII
digestion, pattern 1 after MseI digestion, and
pattern 1 after RsaI digestion, whereas geno-
type E was defined as showing pattern 1 after
HindII digestion and pattern 2 after MseI and RsaI
digestion. Table 2 presents the size of the different
DNA fragments, pattern groups and T. vaginalis
actin genotypes of the T. vaginalis isolates. Isolates
with similar DNA patterns were considered to be
a single T. vaginalis actin type.
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The T. vaginalis actin genotypes of the reference
strains were determined to be as follows: ATCC
30001 = genotype G; ATCC 30240 = genotype H;
ATCC 50141 = genotype E; ATCC 50144 = geno-
type G; and Tv 17–48 = genotype E.
Separation of the DNA fragments by gel electro-
phoresis is shown in Fig. 1 for the T. vaginalis actin
genotypes of the ATCC reference strains 30001,
30240 and 50141, genotypes G, H and E, respec-
tively. Fig. 2 shows the gel electrophoresis patterns
of the DNA fragments of the isolates Kinshasa
K2143, Zambia N133, and Zambia N74, which
represent actin genotypes M, E and H, respec-
tively.
Assessment of robustness and reproducibility of
the PCR-RFLP
Amplification and digestion of the amplicons on
different days gave identical DNA fragments.
Nucleotide sequences
Supplementary Fig. S1 shows the alignment of
the sequences of the actin gene target of the
strains ATCC 30001 (GenBank accession number
EU076578), ATCC 30240 (GenBank accession
number EU076579), ATCC 50141 (GenBank
accession number EU076580), strain K2143* (Gen-
Bank accession number EU076583) and strain
K1086 (GenBank accession number EU076584)
from Kinshasa, and strains N78 (GenBank acces-
sion number EU076585) and N113 (GenBank
accession number EU076586) from Zambia,
against the sequences described by Espinosa et al.
(GenBank accession number AF237734) and by
Bricheux et al. (GenBank accession number
U63122) [25,28].
In total, 15 different single nucleotide changes
in the open reading frame of the actin gene were
detected. Three of them, nucleotides 371, 575,
and 904, resulted in an amino acid substitution.
Geographical distribution of the Tv actin
genotypes
The T. vaginalis RFLP types were determined for
61 isolates from Kinshasa, and for 90 isolates from
Fig. 2. Gel electrophoresis of DNA fragments obtained
after digestion of the Tv actin genotypes M, E, and H.
Lanes 1, 2 and 3 show the banding pattern after digestion
with HindII, MseI, and RsaI, respectively, of speci-
men K2143, genotype M; lane 4 is a 100-bp DNA ladder;
lanes 5, 6 and 7 show the banding pattern after digestion
with HindII, MseI, and RsaI, respectively, of speci-
men N133, genotype E; lanes 8, 9 and 10 show the banding
pattern after digestion with HindII, MseI, and RsaI, respec-
tively, of specimen N74, genotype H. The faint, less inten-
sive, bands of higher sizes were not scored.
Fig. 1. Gel electrophoresis of DNA fragments obtained
after digestion of the Tv actin genotypes G, H, and E.
Lanes 1, 2 and 3 show the banding pattern after digestion
with HindII, MseI, and RsaI, respectively, of ATCC 30001,
genotype G; lanes 4, 5 and 6 show the banding pattern
after digestion with HindII, MseI, and RsaI, respectively, of
ATCC 30240, genotype H; lane 7 is a 100-bp DNA ladder;
lanes 8, 9 and 10 show the banding pattern after digestion
with HindII, MseI, and RsaI, respectively, of ATCC 50141,
genotype E. The faint, less intensive, bands of higher sizes
were not scored.
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Zambia. Eight different types were identified
among the isolates from Kinshasa and Zambia.
One isolate from Kinshasa could not be typed.
The distribution of the types is presented in
Table 3. In Kinshasa, the most common type was
type E (57% of isolates), whereas in Zambia the
most common type was type G (47% of isolates).
Patterns that were suggestive of mixed infection
were found in Zambia (11% of isolates) but not in
Kinshasa.
D I S C U S S I O N
Strain typing techniques are useful tools to
study the epidemiology of infectious organisms.
They provide information on the nature and
extent of genetic diversity of the organism in a
specific population [12]. For T. vaginalis in par-
ticular, the technique can be used to study
modes of transmission, pathogenicity and drug
resistance.
So far, only two promising molecular typing
techniques for T. vaginalis have been described in
the literature, including an RAPD technique
described by Vanacova et al. [13], and an RFLP
technique followed by hybridization with a heat
shock protein 70 (HSP70) probe described by
Stiles et al. [14]. Vanacova et al. [13] used five
random primers (OPD1–OPD5) and two primers
complementary to the T. vaginalis repetitive frag-
ment TV E-650, and included ATCC reference
strains. The same technique was applied by two
other research groups using four (OPD1, OPD2,
OPD3, OPD5) and five (OPD1–OPD5) random
primers, respectively [29,30]. It is not clear
whether the same reference strains were used,
and if identical RAPD patterns were obtained,
which would have confirmed the validity of the
results. Kaul and colleagues found that isolates
from symptomatic women appeared to form two
distinct clusters, whereas Snipes et al. found
certain RADP patterns to be associated with
metronidazole resistance. Fraga et al. [16] opti-
mized the RAPD technique by designing ten
random primers (Tv1–Tv10). Using this method,
an association was found between the genetic
variability of T. vaginalis and clinical presentation
of infection. A genetic marker of 490 bp appeared
to be present only in isolates from symptomatic
patients [31]. Stiles et al. published an RFLP
technique in which T. vaginalis DNA was
digested with EcoRI. Fragments were transferred
to a nylon membrane, and this was followed by
hybridization with a HSP70 probe. For each of the
five ATCC reference strains, they obtained a
unique EcoRI HSP70 RFLP profile. They could
not find an association between metronidazole
resistance and RFLP subtypes [14].
In this study, an PCR-RFLP technique was
applied, combining the higher sensitivity of the
PCR with the reliability of the RFLP. The actin
gene was selected as the target, on the basis of the
role of actin in the morphological changes of the
parasite. Actin is a ubiquitous protein involved in
the formation of filaments, which constitute a
major component of the cytoskeleton. It provides
the basis for muscular contraction and many
aspects of cell motility. T. vaginalis changes from
the flagellate to the amoeboid form when it
adheres to the host cells, and pseudopods are
formed at the site of contact [28]. The ability to
undergo morphological changes is presumed to
be related to virulence, and the importance of
cytoskeletal integrity for T. vaginalis cytopathog-
enicity has been highlighted [32–34]. Actin might
thus play a role in the pathogenesis of the
parasite. The actin protein of T. vaginalis is
encoded within a family of at least nine genes
[25,28]. The internal transcribed spacer region of
the rDNA was not considered to be the target for
the PCR-RFLP, as Snipes et al. [29] concluded that
the internal transcribed spacer region of T. vagi-
nalis, in contrast to those of other organisms,
lacked variability. Recently, a PCR-RFLP tech-
nique for T. vaginalis that included amplification
of the ribosomal intergenic spacer regions and
digestion with eight restriction enzymes was
published. However, the observed polymorphism
was not significant, and sequence information on
the amplified intergenic spacer rDNA was lacking
[35].
Table 3. Prevalence of the Trichomonas vaginalis actin
genotypes in Kinshasa and Zambia
Tv actin genotype
No. of T. vaginalis actin genotype
Kinshasa, n (%), N = 61 Zambia, n (%), N = 90
A 1 (1.6) 1 (1.1)
E 34 (55.7) 5 (5.5)
G 14 (23.0) 42 (46.7)
H 6 (9.8) 15 (16.7)
I 1 (1.6) 6 (6.7)
M 2 (3.2) 0
N 2 (3.2) 6 (6.7)
P 0 5 (5.6)
Mixed 0 10 (11.0)
Not typeable 1 (1.6)
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The PCR-RFLP technique described here
enabled identification of a total of eight different
T. vaginalis types. In addition, different fragment
patterns obtained for types E, G, H, I, M, N and P
were confirmed with the determination of their
respective nucleotide sequences. Different distri-
butions of types were found in Kinshasa (Dem-
ocratic Republic of Congo) and Zambia. Patterns
suggestive of mixed infections were found only in
Zambia. The absence of mixed infections in
Kinshasa could be explained by the much lower
prevalence of trichomoniasis among women in
Kinshasa than among women in Zambia (8.6% vs.
30.1%) [21]. The T. vaginalis actin genotypes of the
reference strains were not different from the types
detected in Kinshasa and Zambia, confirming
the findings of Stiles et al. [14], who describe
the stability of T. vaginalis strains. The stability of
the genotypes is in line with the clonal reproduc-
tion of parasitic protozoa, resulting in the
production of clones that are stable over time
and across geographical areas [14].
The discriminative ability of our method is
comparable to that of the RFLP technique target-
ing HSP70 described by Stiles et al. [14]. With this
technique, ten different types were identified.
However, the overall discriminative power of the
designed method was low. The actin gene may
not be a suitable marker for strain discrimination
if it is used on its own, but the overall discrim-
inative power can be improved if a combination
of markers for strain discrimination is used [36].
There was 100% similarity in this study
between the nucleotide sequences of reference
strain ATCC 50141, clinical isolate N133, both
actin genotypes E, and the actin clone sequence
reported by Espinosa et al. [25]. Among the other
determined nucleotide sequences, 15 different
single nucleotide changes were observed in the
open reading frame of the actin gene. Twelve
were silent mutations, and three were missense
mutations resulting in an amino acid substitution
in the primary protein structure of the actin. The
simultaneous three amino acid substitutions
occurred in genotype G; nucleotide 371 substi-
tuted alanine for valine, nucleotide 575 substi-
tuted glycine for aspartic acid, and nucleotide 904
substituted lysine for glutamine. Genotypes H, M,
I and P all showed the same two amino acid
substitutions; alanine was substituted for valine,
and lysine for glutamine. The only missense
mutation detected in the nucleotide sequence of
genotype N resulted in substitution of alanine for
valine. The nucleotide sequence of genotype A
was not determined.
In this study, at least ten trophozoites were
needed per reaction to have an adequate concen-
tration of amplicons for the restriction assays.
The longer target size was selected to determine
the maximal numbers of mutations. However, on
the basis of these results, shortening of the target
size could be considered, which may increase the
sensitivity of the nested PCR, and make it even-
tually more suitable for the application of the
PCR-RFLP technique for clinical specimens.
In conclusion, a sensitive, specific and easy-to-
perform strain typing method for T. vaginalis was
developed. The technique was evaluated using
T. vaginalis isolates obtained by in vitro culture of
clinical isolates, which may have led to selective
growth and selection of genotypes [12]. Further
studies should focus on the validation and
application of this typing technique using clinical
specimens. Additional studies are needed to
determine the technique’s particular applica-
tion in molecular epidemiological studies of
T. vaginalis.
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